National Bank Of Canada Coll Plant Biotechnologies LTD Transaction History
National Bank Of Canada
- $72.7 Billion
- Q3 2024
A detailed history of National Bank Of Canada transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, National Bank Of Canada holds 250 shares of CLGN stock, worth $852. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$852
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CLGN
# of Institutions
16Shares Held
2.01MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC485KShares$1.65 Million0.21% of portfolio
-
Pinnacle Associates LTD468KShares$1.6 Million0.04% of portfolio
-
Investment Management Of Virginia LLC464KShares$1.58 Million0.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$942,6262.69% of portfolio
-
Brown Advisory Inc119KShares$407,3750.0% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $37.8M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...